focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 251.50
Bid: 250.50
Ask: 251.50
Change: 2.50 (1.00%)
Spread: 1.00 (0.399%)
Open: 247.00
High: 251.50
Low: 247.00
Prev. Close: 249.00
CSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

17 Apr 2024 10:00

RNS Number : 8678K
Chesnara PLC
17 April 2024
 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

17th April 2024

 

CHESNARA plc

("Chesnara", "the Company" or the "Group")

 

RELEASE OF ANNUAL REPORT & ACCOUNTS AND NOTICE OF AGM

 

Chesnara plc (CSN.L) today announces that its 2024 Annual General Meeting ("AGM") will be held at the offices of Panmure Gordon & Co, 40 Gracechurch Street, London, EC3V 0BT on Tuesday 14th May at 11:00am. In connection with this, the 2023 Annual Report & Accounts, including the Notice of Annual General Meeting, are being posted and/or made available to shareholders today.

 

The Company continues to strongly encourage shareholders to vote electronically. Shareholders may also wish to submit questions in advance via e-mail to info@chesnara.co.uk. We will endeavour to respond to questions raised directly, or by publishing responses on our website. We are also pleased to be able to invite members to attend the AGM in person.

 

The Company's preliminary results for the year ended 31st December 2023 were announced on 28th March 2024. This announcement contained a management report and a condensed set of financial statements prepared in accordance with applicable accounting standards and responsibility statements in compliance with DTR6.3.5R.

 

Copies of the 2023 Annual Report & Accounts and Notice of AGM may be viewed in the Investor Relations section of the Company's website at www.chesnara.co.uk.

 

In accordance with Listing Rule 9.6.1, copies of the 2023 Annual Report & Accounts and the Notice of AGM have been uploaded to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

As previously announced, Mark Hesketh, Independent Non-Executive Director, stepped down from the Board of Chesnara plc on 9 April 2024. As a result, Resolution 9 (which proposed Mark Hesketh's re-appointment as a Director of the Company) is withdrawn from the agenda of the AGM. This withdrawal does not affect the validity of the Notice of AGM, the proxy form or any votes in respect of the remaining resolutions to be proposed at the AGM. The numbering of all other proposed resolutions at the AGM remains unchanged.

 

The Company's Chair, Luke Savage, commented:

'Mark, with his wealth of experience and knowledge of the Group, will be sorely missed at the Chesnara plc Board table, but I am very pleased that the Group will continue to benefit from his expertise as the newly appointed Chair of our UK business. I want to thank him for his contribution to the plc Board and I am looking forward to working closely with him in this important role.'

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493 

E - roddy.watt@fwdconsulting.co.uk

 

 

 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden, the Netherlands and the UK as well as by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 19 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAQQLFFZZLZBBF
Date   Source Headline
20th May 202012:02 pmRNSPrice Monitoring Extension
5th May 20207:00 amRNSDoc re. Rights Attached to Equity Shares
1st May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSHolding(s) in Company
29th Apr 20207:00 amRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSBlock listing Interim Review
23rd Apr 20207:00 amRNSNotice of AGM
15th Apr 20204:00 pmRNSHolding(s) in Company
15th Apr 20207:00 amRNSFinal Results
6th Apr 20203:54 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSTrading Statement
23rd Mar 20207:15 amRNSNotice of Results
20th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20207:00 amRNSNotice of Results
14th Feb 20207:00 amRNSDirectorate Change
17th Dec 20197:00 amRNSChange of Adviser
22nd Nov 20197:00 amRNSAcquisition
25th Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20195:11 pmRNSHolding(s) in Company
22nd Oct 20195:11 pmRNSHolding(s) in Company
2nd Oct 20195:11 pmRNSHolding(s) in Company
30th Sep 20195:00 pmRNSTotal Voting Rights
30th Sep 20192:33 pmRNSHolding(s) in Company
20th Sep 20199:00 amRNSHolding(s) in Company
19th Sep 20195:00 pmRNSHolding(s) in Company
12th Sep 20195:24 pmRNSHolding(s) in Company
9th Sep 20192:11 pmRNSDirector/PDMR Shareholding
2nd Sep 20197:00 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSHalf-year Report
6th Aug 20194:40 pmRNSNotice of Results
31st Jul 20197:00 amRNSTotal Voting Rights
31st May 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSDirector/PDMR Shareholding
14th May 20192:34 pmRNSResult of AGM
7th May 20191:23 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSDirector/PDMR Shareholding
25th Apr 20197:00 amRNSBlock listing Interim Review
16th Apr 20197:00 amRNSNotice of AGM
12th Apr 201910:17 amRNSHolding(s) in Company
29th Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSNotice of Results
31st Dec 20187:00 amRNSTotal Voting Rights
17th Dec 20185:36 pmRNSDirectorate Change
13th Dec 20189:30 amRNSDirector/PDMR Shareholding
12th Dec 20187:00 amRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
6th Nov 20188:27 amRNSDirector/PDMR Shareholding
25th Oct 20187:00 amRNSBlock listing Interim Review
1st Oct 20187:00 amRNSNew Senior Independent Director
30th Aug 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.